Facility # 1

Koto-ku, Tokyo

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma (HCC)

Studies at this site

• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma — Completed